| UniProt ID | CCND1_HUMAN | |
|---|---|---|
| UniProt AC | P24385 | |
| Protein Name | G1/S-specific cyclin-D1 | |
| Gene Name | CCND1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 295 | |
| Subcellular Localization | Nucleus . Cytoplasm . Membrane . Cyclin D-CDK4 complexes accumulate at the nuclear membrane and are then translocated to the nucleus through interaction with KIP/CIP family members.. | |
| Protein Description | Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex. Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner.. | |
| Protein Sequence | MEHQLLCCEVETIRRAYPDANLLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKETIPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRKHAQTFVALCATDVKFISNPPSMVAAGSVVAAVQGLNLRSPNNFLSYYRLTRFLSRVIKCDPDCLRACQEQIEALLESSLRQAQQNMDPKAAEEEEEEEEEVDLACTPTDVRDVDI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 33 | Sumoylation | RVLRAMLKAEETCAP HHHHHHHHHHHHCCC | 40.44 | - | |
| 33 | Ubiquitination | RVLRAMLKAEETCAP HHHHHHHHHHHHCCC | 40.44 | - | |
| 37 | Phosphorylation | AMLKAEETCAPSVSY HHHHHHHHCCCCCCH | 12.89 | 30177828 | |
| 41 | Phosphorylation | AEETCAPSVSYFKCV HHHHCCCCCCHHHHH | 12.74 | 28355574 | |
| 43 | Phosphorylation | ETCAPSVSYFKCVQK HHCCCCCCHHHHHHH | 29.23 | 30108239 | |
| 44 | Phosphorylation | TCAPSVSYFKCVQKE HCCCCCCHHHHHHHH | 12.61 | 30177828 | |
| 46 | Methylation | APSVSYFKCVQKEVL CCCCCHHHHHHHHHH | 25.84 | - | |
| 46 | Ubiquitination | APSVSYFKCVQKEVL CCCCCHHHHHHHHHH | 25.84 | - | |
| 50 | Ubiquitination | SYFKCVQKEVLPSMR CHHHHHHHHHHHHHH | 29.41 | - | |
| 90 | Phosphorylation | NYLDRFLSLEPVKKS HHHHHHHCCCCCCHH | 28.16 | 22817900 | |
| 95 | Ubiquitination | FLSLEPVKKSRLQLL HHCCCCCCHHHHHHH | 56.60 | 21906983 | |
| 96 | Ubiquitination | LSLEPVKKSRLQLLG HCCCCCCHHHHHHHH | 40.83 | - | |
| 111 | Phosphorylation | ATCMFVASKMKETIP HHHHHHHHHCCCCCC | 28.16 | - | |
| 112 | Ubiquitination | TCMFVASKMKETIPL HHHHHHHHCCCCCCC | 44.23 | - | |
| 114 | Ubiquitination | MFVASKMKETIPLTA HHHHHHCCCCCCCCH | 56.28 | 21906983 | |
| 131 | Phosphorylation | LCIYTDNSIRPEELL HHHCCCCCCCHHHHH | 23.84 | - | |
| 149 | Ubiquitination | LLLVNKLKWNLAAMT HHHHHHHHHHHHHCC | 35.33 | - | |
| 167 | Ubiquitination | FIEHFLSKMPEAEEN HHHHHHHCCCHHHHH | 61.70 | 21906983 | |
| 175 | Ubiquitination | MPEAEENKQIIRKHA CCHHHHHHHHHHHHH | 46.27 | 21906983 | |
| 180 | Ubiquitination | ENKQIIRKHAQTFVA HHHHHHHHHHHHHHH | 32.65 | - | |
| 197 | Phosphorylation | ATDVKFISNPPSMVA HCCCHHHCCCHHHHH | 46.55 | 22817900 | |
| 219 | Phosphorylation | VQGLNLRSPNNFLSY HHCCCCCCCCCHHHH | 34.84 | 24719451 | |
| 226 | Phosphorylation | SPNNFLSYYRLTRFL CCCCHHHHHHHHHHH | 8.51 | 17053785 | |
| 234 | Phosphorylation | YRLTRFLSRVIKCDP HHHHHHHHHHHCCCH | 23.07 | 22817900 | |
| 238 | Ubiquitination | RFLSRVIKCDPDCLR HHHHHHHCCCHHHHH | 29.72 | 21906983 | |
| 257 | Phosphorylation | QIEALLESSLRQAQQ HHHHHHHHHHHHHHH | 34.34 | 28450419 | |
| 258 | Phosphorylation | IEALLESSLRQAQQN HHHHHHHHHHHHHHH | 20.42 | 28450419 | |
| 269 | Ubiquitination | AQQNMDPKAAEEEEE HHHHCCHHHHHHHHH | 56.83 | 1976777 | |
| 286 | Phosphorylation | EEVDLACTPTDVRDV HHCCCCCCCCCCCCC | 24.50 | 10766840 | |
| 288 | Phosphorylation | VDLACTPTDVRDVDI CCCCCCCCCCCCCCC | 29.04 | 10766840 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 90 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 90 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 90 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 197 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 197 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 197 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 234 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
| 234 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 234 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 286 | T | Phosphorylation | Kinase | DYRK1A | Q13627 | PSP |
| 286 | T | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
| 286 | T | Phosphorylation | Kinase | CHUK | O15111 | GPS |
| 286 | T | Phosphorylation | Kinase | GSK-FAMILY | - | GPS |
| 286 | T | Phosphorylation | Kinase | IKK-FAMILY | - | GPS |
| 286 | T | Phosphorylation | Kinase | GSK-3_GROUP | - | PhosphoELM |
| 288 | T | Phosphorylation | Kinase | DYRK1B | Q9Y463 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | FBXW8 | Q8N3Y1 | PMID:17205132 |
| - | K | Ubiquitination | E3 ubiquitin ligase | UHRF2 | Q96PU4 | PMID:21952639 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:24658274 |
| - | K | Ubiquitination | E3 ubiquitin ligase | FBXO4 | Q9UKT5 | PMID:17081987 |
| - | K | Ubiquitination | E3 ubiquitin ligase | FBXO31 | Q5XUX0 | PMID:20664978 |
| - | K | Ubiquitination | E3 ubiquitin ligase | HACE1 | Q8IYU2 | PMID:17694067 |
| - | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:11439327 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCND1_HUMAN !! | ||||||
| Kegg Disease | |
|---|---|
| H00006 | Hairy-cell leukemia |
| H00010 | Multiple myeloma |
| H00016 | Oral cancer |
| H00017 | Esophageal cancer |
| H00031 | Breast cancer |
| H00047 | Gallbladder cancer |
| H00055 | Laryngeal cancer |
| H00559 | von Hippel-Lindau syndrome |
| OMIM Disease | |
| Note=A chromosomal aberration involving CCND1 may be a cause of B-lymphocytic malignancy, particularly mantle-cell lymphoma (MCL). Translocation t(11 | |
| 14)(q13 | |
| q32) with immunoglobulin gene regions. Activation of CCND1 may be oncogenic by directly altering progression through the cell cycle. | |
| 254500 | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB01169 | Arsenic trioxide |
loading...
| Phosphorylation | |
| Reference | PubMed |
| "F-box protein FBXO31 mediates cyclin D1 degradation to induce G1arrest after DNA damage."; Santra M.K., Wajapeyee N., Green M.R.; Nature 459:722-725(2009). Cited for: PHOSPHORYLATION AT THR-286, UBIQUITINATION, AND MUTAGENESIS OFTHR-286. | |
| "Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-226, AND MASSSPECTROMETRY. | |